Guna-Diur
Generic name: amiloride, apis mellifera, berberis vulgaris fruit, hydrochlorothiazide, sus scrofa pituitary gland, hieracium pilosella flowering top, solidago virgaurea flowering top and spironolactone
Dosage form: oral solution / drops
Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Drug Abuse and Dependence
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- References
- Patient Counseling Information
1. INDICATIONS AND USAGE
1.1 Temporary relief of fluid retention
1.2 Tissue swelling and related disconforts
2. DOSAGE AND ADMINISTRATION
Adults: 20 drops in a little water, 2 times per day for an avarage of two months.
Stop use and ask a doctor if symptoms persist more than 5 days.
Administration may very according to individual needs.
Guna-Diur may be used together with other homeopthic medicines.
3. DOSAGE FORMS AND STRENGTHS
3.1. 30 ml Bottle dropper container contains:
Active ingredients: Amiloride 4X 0.006 ml, Apis Mellifica 2X 0.626 ml, Berberis Vulgaris T 0.314 ml, Hydrochlorothiazide 4X 0.006 ml, Hypophysis 12X 6.314 ml, Mouse-Ear Hawkweed T 6.314 ml, Solidago Virgaurea T 0.314 ml, Spironolactone 4X 0.006 ml.
Inactive Ingredient: Ethylic Alcohol 30%
4. CONTRAINDICATIONS
4.1. There is no history of hypersensitivity to Guna-Diur. However, do not use if you are hypersensitive to any of the active ingredients of Guna-Diur.
5. WARNINGS AND PRECAUTIONS
5.1. Guna-Diur is contraindicated in patients with anuria and in patients with a history of hypersensitivity to Spironolactone, Amiloride, or Hydrocholorthiazide.
5.2. Use with caution in patients taking diuretic medications.
5.3 Keep out of reach of children.
6. ADVERSE REACTIONS
6.1.